- Home
- TCBI vs ICUI Comparison
TCBI vs ICUI Comparison
Compare TCBI & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBI
- ICUI
- Stock Information
- Founded
- TCBI 1996
- ICUI 1984
- Country
- TCBI United States
- ICUI United States
- Employees
- TCBI N/A
- ICUI N/A
- Industry
- TCBI Major Banks
- ICUI Medical/Dental Instruments
- Sector
- TCBI Finance
- ICUI Health Care
- Exchange
- TCBI Nasdaq
- ICUI Nasdaq
- Market Cap
- TCBI 3.9B
- ICUI 3.2B
- IPO Year
- TCBI N/A
- ICUI 1992
- Fundamental
- Price
- TCBI $86.26
- ICUI $138.64
- Analyst Decision
- TCBI Hold
- ICUI Buy
- Analyst Count
- TCBI 10
- ICUI 6
- Target Price
- TCBI $85.20
- ICUI $183.60
- AVG Volume (30 Days)
- TCBI 601.8K
- ICUI 290.1K
- Earning Date
- TCBI 10-22-2025
- ICUI 11-06-2025
- Dividend Yield
- TCBI N/A
- ICUI N/A
- EPS Growth
- TCBI 2948.16
- ICUI N/A
- EPS
- TCBI 6.10
- ICUI N/A
- Revenue
- TCBI $1,149,977,000.00
- ICUI $2,320,363,000.00
- Revenue This Year
- TCBI $47.92
- ICUI N/A
- Revenue Next Year
- TCBI $7.81
- ICUI N/A
- P/E Ratio
- TCBI $14.23
- ICUI N/A
- Revenue Growth
- TCBI 39.14
- ICUI N/A
- 52 Week Low
- TCBI $59.37
- ICUI $107.00
- 52 Week High
- TCBI $94.61
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- TCBI 55.80
- ICUI 73.86
- Support Level
- TCBI $81.27
- ICUI $116.21
- Resistance Level
- TCBI $86.28
- ICUI $120.60
- Average True Range (ATR)
- TCBI 2.42
- ICUI 4.88
- MACD
- TCBI 0.34
- ICUI 1.92
- Stochastic Oscillator
- TCBI 88.79
- ICUI 69.73
About TCBI Texas Capital Bancshares Inc.
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.